LQDA: Liquidia Corporation Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,170.30
Enterprise Value ($M) 1,119.04
Book Value ($M) 77.28
Book Value / Share 0.91
Price / Book 15.10
NCAV ($M) 32.07
NCAV / Share 0.38
Price / NCAV 36.39

Profitability (mra)
Return on Invested Capital (ROIC) -0.61
Return on Assets (ROA) -0.66
Return on Equity (ROE) -1.51

Liquidity (mrq)
Quick Ratio 4.42
Current Ratio 4.43

Balance Sheet (mrq) ($M)
Current Assets 185.10
Assets 230.31
Liabilities 153.04
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 14.00
Operating Income -121.29
Net Income -130.39

Cash Flow Statement (mra) ($M)
Cash From Operations -93.42
Cash from Investing -8.44
Cash from Financing 194.66

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-12 13G/A Legend Aggregator, LP 2.20 -74.10
11-12 13G/A Manning Paul B 7.90 5.54
11-08 13G BlackRock, Inc. 5.00 0.00
09-12 13D/A Caligan Partners LP 9.80 16.06

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 109,800 524,353 20.94
2025-04-16 171,874 599,354 28.68
2025-04-15 131,264 586,888 22.37
2025-04-14 208,629 831,832 25.08

(click for more detail)

Similar Companies
LIXT – Lixte Biotechnology Holdings, Inc. LPCN – Lipocine Inc.
LPTX – Leap Therapeutics, Inc. LSTA – Lisata Therapeutics, Inc.
LTRN – Lantern Pharma Inc.


Financial data and stock pages provided by
Fintel.io